Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Spagnolo

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Critical Reviews in Oncology/Hematology|January 31, 2024
The treatment of advanced melanoma: Current approaches and new challengesAndrea Boutros, Elena Croce, Marco Ferrari, et al.
Cancers|June 2, 2021
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic VariantsFrancesco Spagnolo, Bruna Dalmasso, Enrica Tanda, et al.
Therapeutic Advances in Medical Oncology|December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centersMaristella Saponara, Laura Pala, Fabio Conforti, et al.
Dermatology Reports|March 12, 2025
Survey of the impact of BOLT-trial data on oncologists' and dermatologists' decision-making in treating patients with locally advanced basal cell carcinomaLuigi Scarpato, Marco Palla, Sabino Strippoli, et al.
Cancers|April 30, 2021
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal MelanomaMariarosaria Marseglia, Adriana Amaro, Nicola Solari, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Marco Bruzzone, Enrica T Tanda, et al.
International Journal of Molecular Sciences|February 10, 2024
Machine Learning Methods for Gene Selection in Uveal MelanomaFrancesco Reggiani, Zeinab El Rashed, Mariangela Petito, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Frontiers in Oncology|November 13, 2025
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case reportEnrica Teresa Tanda, Agostina Lagodin D'Amato, Giovanni Rossi, et al.
Acta Dermato-Venereologica|April 13, 2018
Effect of Age on Melanoma Risk, Prognosis and Treatment ResponseSimone Ribero, Luigia Stefania Stucci, Elena Marra, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Critical Reviews in Oncology/Hematology|January 31, 2024
The treatment of advanced melanoma: Current approaches and new challengesAndrea Boutros, Elena Croce, Marco Ferrari, et al.
Cancers|June 2, 2021
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic VariantsFrancesco Spagnolo, Bruna Dalmasso, Enrica Tanda, et al.
Therapeutic Advances in Medical Oncology|December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centersMaristella Saponara, Laura Pala, Fabio Conforti, et al.
Dermatology Reports|March 12, 2025
Survey of the impact of BOLT-trial data on oncologists' and dermatologists' decision-making in treating patients with locally advanced basal cell carcinomaLuigi Scarpato, Marco Palla, Sabino Strippoli, et al.
Cancers|April 30, 2021
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal MelanomaMariarosaria Marseglia, Adriana Amaro, Nicola Solari, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Marco Bruzzone, Enrica T Tanda, et al.
International Journal of Molecular Sciences|February 10, 2024
Machine Learning Methods for Gene Selection in Uveal MelanomaFrancesco Reggiani, Zeinab El Rashed, Mariangela Petito, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Frontiers in Oncology|November 13, 2025
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case reportEnrica Teresa Tanda, Agostina Lagodin D'Amato, Giovanni Rossi, et al.
Acta Dermato-Venereologica|April 13, 2018
Effect of Age on Melanoma Risk, Prognosis and Treatment ResponseSimone Ribero, Luigia Stefania Stucci, Elena Marra, et al.
Pageof 12